APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hay Fever and Allergic Rhinitis Decongestants Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchHay Fever and Allergic Rhinitis Decongestants Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hay Fever and Allergic Rhinitis Decongestants Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hay Fever and Allergic Rhinitis Decongestants Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hay Fever and Allergic Rhinitis Decongestants Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hay Fever and Allergic Rhinitis Decongestants Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hay Fever and Allergic Rhinitis Decongestants Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug include Shenzhen Daphne, Johnson & Johnson, Nanjing Tianlang, Nanjing Haijing, Mingsheng Pharma, Dandong Pharma, Procter & Gamble, Bayer and Foundation Consumer Brands, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hay Fever and Allergic Rhinitis Decongestants Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hay Fever and Allergic Rhinitis Decongestants Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Hay Fever and Allergic Rhinitis Decongestants Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hay Fever and Allergic Rhinitis Decongestants Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hay Fever and Allergic Rhinitis Decongestants Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hay Fever and Allergic Rhinitis Decongestants Drug sales, projected growth trends, production technology, application and end-user industry.

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Company

Shenzhen Daphne

Johnson & Johnson

Nanjing Tianlang

Nanjing Haijing

Mingsheng Pharma

Dandong Pharma

Procter & Gamble

Bayer

Foundation Consumer Brands

B.F. Ascher & Company

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Type

Nasal Spray

Tablet

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Application

Clinic

Hospital

Pharmacy Retail

Other

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hay Fever and Allergic Rhinitis Decongestants Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hay Fever and Allergic Rhinitis Decongestants Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hay Fever and Allergic Rhinitis Decongestants Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hay Fever and Allergic Rhinitis Decongestants Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hay Fever and Allergic Rhinitis Decongestants Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hay Fever and Allergic Rhinitis Decongestants Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nasal Spray Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Pharmacy Retail Major Manufacturers Table 8. Other Major Manufacturers Table 9. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends Table 10. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers Table 11. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges Table 12. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints Table 13. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2026) Table 17. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2027-2032) Table 18. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026) & (k units) Table 20. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2027-2032) & (k units) Table 21. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2026) Table 22. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2027-2032) Table 23. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Hay Fever and Allergic Rhinitis Decongestants Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Hay Fever and Allergic Rhinitis Decongestants Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers, Product Type & Application Table 31. Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Hay Fever and Allergic Rhinitis Decongestants Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2026) Table 38. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2027-2032) Table 39. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 41. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 42. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2026) Table 43. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2027-2032) Table 44. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2026) & (US$/unit) Table 45. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2027-2032) & (US$/unit) Table 46. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2026) Table 50. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2027-2032) Table 51. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 53. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 54. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2026) Table 55. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2027-2032) Table 56. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2026) & (US$/unit) Table 57. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2027-2032) & (US$/unit) Table 58. Shenzhen Daphne Company Information Table 59. Shenzhen Daphne Business Overview Table 60. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 62. Shenzhen Daphne Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Nanjing Tianlang Company Information Table 69. Nanjing Tianlang Business Overview Table 70. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 72. Nanjing Tianlang Recent Development Table 73. Nanjing Haijing Company Information Table 74. Nanjing Haijing Business Overview Table 75. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 77. Nanjing Haijing Recent Development Table 78. Mingsheng Pharma Company Information Table 79. Mingsheng Pharma Business Overview Table 80. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 82. Mingsheng Pharma Recent Development Table 83. Dandong Pharma Company Information Table 84. Dandong Pharma Business Overview Table 85. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 87. Dandong Pharma Recent Development Table 88. Procter & Gamble Company Information Table 89. Procter & Gamble Business Overview Table 90. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 92. Procter & Gamble Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 97. Bayer Recent Development Table 98. Foundation Consumer Brands Company Information Table 99. Foundation Consumer Brands Business Overview Table 100. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 102. Foundation Consumer Brands Recent Development Table 103. B.F. Ascher & Company Company Information Table 104. B.F. Ascher & Company Business Overview Table 105. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 107. B.F. Ascher & Company Recent Development Table 108. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 111. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 112. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2021-2026) & (US$/unit) Table 113. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2027-2032) & (US$/unit) Table 114. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 117. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 118. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2021-2026) & (US$/unit) Table 119. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2027-2032) & (US$/unit) Table 120. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 124. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 125. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 126. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2021-2026) & (US$/unit) Table 127. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2027-2032) & (US$/unit) Table 128. United States Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 129. Canada Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 130. Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 131. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 134. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 135. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2021-2026) & (US$/unit) Table 136. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2027-2032) & (US$/unit) Table 137. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 140. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 141. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2021-2026) & (US$/unit) Table 142. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2027-2032) & (US$/unit) Table 143. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 147. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 148. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 149. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2021-2026) & (US$/unit) Table 150. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2027-2032) & (US$/unit) Table 151. Germany Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 152. France Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 153. U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 154. Italy Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 155. Russia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 156. Spain Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 159. Sweden Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 160. Poland Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 161. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 162. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 163. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 164. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 165. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2021-2026) & (US$/unit) Table 166. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2027-2032) & (US$/unit) Table 167. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 168. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 169. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 170. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 171. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2021-2026) & (US$/unit) Table 172. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2027-2032) & (US$/unit) Table 173. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 176. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 177. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2021-2026) & (US$/unit) Table 178. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2027-2032) & (US$/unit) Table 179. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 182. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 183. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2021-2026) & (US$/unit) Table 184. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2027-2032) & (US$/unit) Table 185. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 190. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 191. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2021-2026) & (US$/unit) Table 192. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2027-2032) & (US$/unit) Table 193. Japan Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 194. South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 195. India Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 196. Australia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 202. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 203. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2021-2026) & (US$/unit) Table 204. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Type (2027-2032) & (US$/unit) Table 205. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 208. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 209. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2021-2026) & (US$/unit) Table 210. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Application (2027-2032) & (US$/unit) Table 211. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 215. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 216. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 217. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2021-2026) & (US$/unit) Table 218. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Country (2027-2032) & (US$/unit) Table 219. Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 220. Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 221. Chile Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 222. Colombia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 223. Peru Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 225. Israel Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 226. UAE Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 227. Turkey Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 228. Iran Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 229. Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Hay Fever and Allergic Rhinitis Decongestants Drug Distributors List Table 233. Hay Fever and Allergic Rhinitis Decongestants Drug Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Hay Fever and Allergic Rhinitis Decongestants Drug Image Figure 2. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nasal Spray Image Figure 5. Tablet Image Figure 6. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Pharmacy Retail Image Figure 11. Other Image Figure 12. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (2021-2032) & (k units) Figure 18. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Sales YoY (2021-2032) & (k units) Figure 21. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales YoY (2021-2032) & (k units) Figure 22. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Hay Fever and Allergic Rhinitis Decongestants Drug Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales YoY (2021-2032) & (k units) Figure 25. Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032) Figure 34. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032) Figure 40. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Type (2021-2032) Figure 41. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Type (2021-2032) Figure 42. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Application (2021-2032) Figure 43. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Application (2021-2032) Figure 44. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Country (2021-2032) Figure 45. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Country (2021-2032) Figure 46. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Type (2021-2032) Figure 47. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Type (2021-2032) Figure 48. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Application (2021-2032) Figure 49. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Application (2021-2032) Figure 50. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Country (2021-2032) Figure 51. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Country (2021-2032) Figure 52. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Type (2021-2032) Figure 53. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Type (2021-2032) Figure 54. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Application (2021-2032) Figure 55. China Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Application (2021-2032) Figure 56. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Type (2021-2032) Figure 57. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Type (2021-2032) Figure 58. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Application (2021-2032) Figure 59. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Application (2021-2032) Figure 60. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Country (2021-2032) Figure 61. Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Hay Fever and Allergic Rhinitis Decongestants

Scope & coverage.

Types
  • Nasal Spray
  • Tablet
Applications
  • Clinic
  • Hospital
  • Pharmacy Retail
  • Other
Companies covered
  • Shenzhen Daphne
  • Johnson & Johnson
  • Nanjing Tianlang
  • Nanjing Haijing
  • Mingsheng Pharma
  • Dandong Pharma
  • Procter & Gamble
  • Bayer
  • Foundation Consumer Brands
  • B.F. Ascher & Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Type
  3. 1.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nasal Spray
  5. 1.2.3 Tablet
  6. 1.3 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Application
  7. 1.3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Pharmacy Retail
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Hay Fever and Allergic Rhinitis Decongestants Drug Market Dynamics
  1. 2.1 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends
  2. 2.2 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers
  3. 2.3 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges
  4. 2.4 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region
  3. 3.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region
  9. 3.4.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Manufacturers
  2. 4.1.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Manufacturers
  6. 4.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hay Fever and Allergic Rhinitis Decongestants Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers, Product Type & Application
  13. 4.7 Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market CR5 and HHI
  16. 4.8.2 2025 Hay Fever and Allergic Rhinitis Decongestants Drug Tier 1, Tier 2, and Tier 3
5 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Type
  1. 5.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type
  2. 5.1.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type
  6. 5.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type
6 Hay Fever and Allergic Rhinitis Decongestants Drug Market by Application
  1. 6.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application
  2. 6.1.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application
  6. 6.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application
7 Company Profiles
  1. 7.1 Shenzhen Daphne
  2. 7.1.1 Shenzhen Daphne Company Information
  3. 7.1.2 Shenzhen Daphne Business Overview
  4. 7.1.3 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  6. 7.1.5 Shenzhen Daphne Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Nanjing Tianlang
  14. 7.3.1 Nanjing Tianlang Company Information
  15. 7.3.2 Nanjing Tianlang Business Overview
  16. 7.3.3 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  18. 7.3.5 Nanjing Tianlang Recent Developments
  19. 7.4 Nanjing Haijing
  20. 7.4.1 Nanjing Haijing Company Information
  21. 7.4.2 Nanjing Haijing Business Overview
  22. 7.4.3 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  24. 7.4.5 Nanjing Haijing Recent Developments
  25. 7.5 Mingsheng Pharma
  26. 7.5.1 Mingsheng Pharma Company Information
  27. 7.5.2 Mingsheng Pharma Business Overview
  28. 7.5.3 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  30. 7.5.5 Mingsheng Pharma Recent Developments
  31. 7.6 Dandong Pharma
  32. 7.6.1 Dandong Pharma Company Information
  33. 7.6.2 Dandong Pharma Business Overview
  34. 7.6.3 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  36. 7.6.5 Dandong Pharma Recent Developments
  37. 7.7 Procter & Gamble
  38. 7.7.1 Procter & Gamble Company Information
  39. 7.7.2 Procter & Gamble Business Overview
  40. 7.7.3 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  42. 7.7.5 Procter & Gamble Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Foundation Consumer Brands
  50. 7.9.1 Foundation Consumer Brands Company Information
  51. 7.9.2 Foundation Consumer Brands Business Overview
  52. 7.9.3 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  54. 7.9.5 Foundation Consumer Brands Recent Developments
  55. 7.10 B.F. Ascher & Company
  56. 7.10.1 B.F. Ascher & Company Company Information
  57. 7.10.2 B.F. Ascher & Company Business Overview
  58. 7.10.3 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  60. 7.10.5 B.F. Ascher & Company Recent Developments
8 North America
  1. 8.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type
  2. 8.1.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
  5. 8.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application
  6. 8.2.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
  9. 8.3 North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country
  10. 8.3.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hay Fever and Allergic Rhinitis Decongestants Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type
  2. 9.1.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
  5. 9.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application
  6. 9.2.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
  9. 9.3 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country
  10. 9.3.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type
  2. 10.1.1 China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  4. 10.1.3 China Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
  5. 10.2 China Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application
  6. 10.2.1 China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  8. 10.2.3 China Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type
  2. 11.1.1 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
  5. 11.2 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application
  6. 11.2.1 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
  9. 11.3 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country
  10. 11.3.1 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hay Fever and Allergic Rhinitis Decongestants Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Type
  2. 12.1.1 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Application
  6. 12.2.1 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country
  10. 12.3.1 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hay Fever and Allergic Rhinitis Decongestants Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hay Fever and Allergic Rhinitis Decongestants Drug Value Chain Analysis
  2. 13.1.1 Hay Fever and Allergic Rhinitis Decongestants Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hay Fever and Allergic Rhinitis Decongestants Drug Production Mode & Process
  6. 13.2 Hay Fever and Allergic Rhinitis Decongestants Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hay Fever and Allergic Rhinitis Decongestants Drug Distributors
  9. 13.2.3 Hay Fever and Allergic Rhinitis Decongestants Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst